ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ARS Pharmaceuticals
ARS Pharmaceuticals is seeking a field-based sales professional responsible for increasing brand awareness and product adoption for their FDA-approved needle-free epinephrine product. The role involves engaging healthcare providers, building relationships, and executing territory strategies to support the company's growth and market presence.
ARS Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative treatments for severe allergic reactions and anaphylaxis. The company is best known for neffy, an intranasal epinephrine product designed as a needle-free alternative for emergency allergy treatment, and operates in the biotechnology and specialty pharmaceuticals industry.
GlobeNewswireARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
Nov 10, 2025
Investing News NetworkARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy
Sep 13, 2025
Quiver QuantitativeARS Pharmaceuticals Reports $72.2 Million U.S. Revenue for neffy® in 2025, Announces Phase 2b CSU Data Expected Mid-2026
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ARS Pharmaceuticals.
70% above the average for this role
ReutersEpinephrine nasal spray maker ARS sues Aptar alleging device supply monopoly
Oct 1, 2025
Aquestive Therapeutic Specialty Representative
Aquestive Therapeutics
Aquestive Therapeutic Specialty Representative
Aquestive Therapeutics
Therapeutic Specialty Representative San Diego, CA
Manatal
Aquestive Therapeutic Specialty Representative
Aquestive Therapeutics
Aquestive Therapeutic Specialty Representative
Aquestive Therapeutics
Aquestive Therapeutic Specialty Representative
Aquestive Therapeutics
